What We Do
Pharmaceutical R&D for bioactive proteins that improve human and animal health and that lower healthcare costs. When necessary we fix structural problems using enhanced software tools. These technologies have been successfully applied to a wide range of protein therapeutics including protein and peptide hormones, enzymes, and monoclonal antibodies.
Meet The Team
Russ Lehrman, PhD
Co-Founder and VP of Chemistry at SnapDNA. SPARK Advisor (Stanford), CLSA Fellow, and expert witness. Previously, Russ was Senior Director at InteKrin, Director at Elan, and NeXstar and a technical leader at Nektar. Dr. Lehrman is an expert in pharmaceutical sciences with emphasis on biotherapeutic R&D for parenterally-administered and pulmonary products. He received his Ph.D. in Medicinal Chemistry at UW-Madison.
Lucia Mokres, DVM
VP of Business Development
Founder and Principal of Araneae Biotech Consulting, LLC. She was previously the Chief Medical Officer of EpiBiome, Inc. Lucia led the Epibiome team through the UCSF I-Corps program and helped raise $6m in seed and Series A funding for that company. She is also on the Advisory Board of the Association for Women in Science Stem2Market. Previously, she was Principal Clinical Scientist at Abbott Vascular. Dr. Mokres received her DVM from Colorado State University
Ehud Goldin, PhD
VP of Biology R&D
Co-Founder and CSO of Angular Medicine. In addition, Dr. Goldin is a SPARK (Stanford) Advisor. Previously, he was Chief Scientist at SENS Research and a rare disease expert at the National Institutes of Health NINDS and NHGRI institutes. Dr. Goldin received his Ph.D. in Neurochemistry from the Weizmann Institute in Israel.
BioSuperior Technology, Inc. understands the challenges facing the Biotechnology community, patients and physicians in delivering the best possible biotherapeutics. Talk with us today about how we can work together to apply our skills to improving the quality and effectiveness of your protein candidates. We offer free initial consultation. You are invited to ask for professional perspective on a relevant issue; please use the contact form or call or email us directly. We look forward to hearing from you!